InVivo Therapeutics Holdings buy Maxi_Scalibusa
Start price
23.01.21
/
0%
€35.75
Target price
23.01.22
-
Performance (%)
-73.67%
End price
24.01.22
€9.41
Summary
This prediction ended on 24.01.22 with a price of €9.41. Massive losses of -73.67% were the result for the BUY prediction by Maxi_Scalibusa.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| InVivo Therapeutics Holdings | - | - | - | - |
| iShares Core DAX® | 1.014% | 2.699% | 4.363% | 51.689% |
| iShares Nasdaq 100 | -6.470% | -8.771% | 18.004% | 67.992% |
| iShares Nikkei 225® | -6.517% | -12.580% | 40.915% | 57.109% |
| iShares S&P 500 | -2.721% | -1.752% | 16.966% | 58.872% |
According to Maxi_Scalibusa what are the pros and cons of InVivo Therapeutics Holdings for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Maxi_Scalibusa for this prediction
In the thread Invivo Therapeutics diskutieren
Buy mit Kursziel 10,0
Kursziel geändert auf 0,0
In the thread Trading InVivo Therapeutics Holdings
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten


